Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Verschraagen M, Koks CH, Schellens JH, Beijnen JH. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol Res 1999;40:301-6. [PMID: 10527640 DOI: 10.1006/phrs.1999.0535] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]

For:	Verschraagen M, Koks CH, Schellens JH, Beijnen JH. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol Res 1999;40:301-6. [PMID: 10527640 DOI: 10.1006/phrs.1999.0535] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]

Number

Cited by Other Article(s)

101

Di Cicco RA, Miller AK, Patterson S, Freed MI. Rosiglitazone Does Not Affect the Steady‐State Pharmacokinetics of Digoxin. J Clin Pharmacol 2000. [DOI: 10.1177/009127000004001225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

102

Zhou H, Walter YH, Smith H, Devineni D, McLeod JF. Nateglinide, a New Mealtime Glucose Regulator. Clin Drug Investig 2000. [DOI: 10.2165/00044011-200019060-00009] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]